Pirfenidone Alleviates Inflammation and Fibrosis of Acute Respiratory Distress Syndrome by Modulating the Transforming Growth Factor-β/Smad Signaling Pathway.

MLA

Paik, Seung Sook, et al. “Pirfenidone Alleviates Inflammation and Fibrosis of Acute Respiratory Distress Syndrome by Modulating the Transforming Growth Factor-β/Smad Signaling Pathway.” International Journal of Molecular Sciences, vol. 25, no. 15, Aug. 2024, p. 8014. EBSCOhost, https://doi.org/10.3390/ijms25158014.

APA

Paik, S. S., Lee, J. M., Ko, I.-G., Kim, S. R., Kang, S. W., An, J., Kim, J. A., Kim, D., Hwang, L., Jin, J.-J., Kim, S.-H., Cha, J.-Y., & Choi, C. W. (2024). Pirfenidone Alleviates Inflammation and Fibrosis of Acute Respiratory Distress Syndrome by Modulating the Transforming Growth Factor-β/Smad Signaling Pathway. International Journal of Molecular Sciences, 25(15), 8014. https://doi.org/10.3390/ijms25158014

Chicago

Paik, Seung Sook, Jeong Mi Lee, Il-Gyu Ko, Sae Rom Kim, Sung Wook Kang, Jin An, Jin Ah Kim, et al. 2024. “Pirfenidone Alleviates Inflammation and Fibrosis of Acute Respiratory Distress Syndrome by Modulating the Transforming Growth Factor-β/Smad Signaling Pathway.” International Journal of Molecular Sciences 25 (15): 8014. doi:10.3390/ijms25158014.